Clinical Trial

The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy

Study acronym: WOLVERINE
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this trial is to evaluate the safety of histotripsy using the HistoSonics Edison System for treatment of BPH.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-03; most recent amendment 2026-04-08.
Status change: Not Yet Recruiting → Recruiting 2026-02-25
Trial Details
NCT Number NCT07214675
Lead Sponsor HistoSonics, Inc.
Conditions Benign Prostatic Hyperplasia
Enrollment 80 participants
Start Date 2026-03-20
Primary Completion 2027-05 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-09